We are opening a new bullish trade on Eli Lilly (NYSE:LLY), the $106 billion manufacturer of pharmaceutical products. LLY skyrocketed higher after its last earnings announcement, in which the company not only beat revenue and earnings expectations but also announced it would be spinning out part of its Elanco Animal Health division in an initial public offering (IPO).